Vladyslav Romaniuk

Vladyslav Romaniuk

Auto-generated profile, based on publicly available information

Vladyslav Romaniuk

Prof. S. T. Dąbrowski Hospital in Puszczykowo S.A., 11 Józefa Ignacego Kraszewskiego Street, 62-040 Puszczykowo, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
VRVladyslav Romaniuk
Vladyslav Romaniuk
ABAgnieszka Benecka
Agnieszka Benecka
ZWZuzanna Wieczorek
Zuzanna Wieczorek
ABAlicja Benecka
Alicja Benecka
USUrszula Szuleta
Urszula Szuleta
ITIga Tartas
Iga Tartas
Diabetes mellitus and depression are two major global health challenges that frequently co-occur, with depression being two to three times more prevalent in individuals with diabetes than in the general population. Current evidence confirms a bidirectional relationship, where depression increases the risk of developing type 2 diabetes by 34%, and diabetes elevates the risk of incident depression by 28%. This systematic review explores the complex biological and psychological mechanisms underlying this interplay. Biological pathways include chronic low-grade inflammation characterized by elevated cytokines (IL-6, TNF-α, CRP), dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis resulting in hypercortisolemia, and impaired neuroplasticity linked to reduced levels of brain-derived neurotrophic factor (BDNF). Additionally, central insulin resistance and neurotransmitter alterations in serotonin and dopamine systems further exacerbate both conditions. Psychological and behavioral mediators include the specific emotional burden of diabetes distress, the significant self-management burden associated with insulin therapy and glucose monitoring, and lifestyle factors such as sedentary behavior, poor diet, and sleep disturbances. The presence of comorbid depression is a critical predictor of poor glycemic control (higher HbA1c), increased microvascular complications (retinopathy, nephropathy), and higher mortality rates. Consequently, clinical management must transition toward integrated, multidisciplinary care models that prioritize universal screening and collaborative treatment strategies. Future research should focus on longitudinal studies and the validation of biomarkers to enable precision medicine and improve the long-term prognosis for these patients.

28 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ITIga Tartas
Iga Tartas
WZWiktoria Zawada
Wiktoria Zawada
KKKrystian Kaczmarek
Krystian Kaczmarek
ZLZofia Jadwiga Leszczyńska
Zofia Jadwiga Leszczyńska
VRVladyslav Romaniuk
Vladyslav Romaniuk
NPNatalia Prankiewicz
Natalia Prankiewicz
Background: Thyroid storm is a rare but catastrophic endocrine emergency arising from decompensated, severe thyrotoxicosis. It triggers rapid multi-organ failure and carries a high mortality rate, particularly among critically ill patients and geriatric populations with significant comorbidities. Because its early constitutional signs are easily misattributed, frontline clinical vigilance is crucial for timely intervention. Aim: This review synthesizes early warning signs, precipitating stressors, diagnostic frameworks, and acute stabilization protocols to guide primary care and emergency clinicians. Materials and Methods: A systematic review of contemporary literature, clinical registries, and international guidelines published between 2016 and 2026 was conducted to evaluate clinical phenotypes, triggering factors, diagnostic criteria, and acute multi-targeted pharmacological strategies. Results: A thyroid storm is almost universally precipitated by acute secondary stressors, such as medication non-compliance, infections, surgery, or trauma. While younger populations typically present with a hyperkinetic phenotype (hyperthermia, severe tachycardia, and central nervous system agitation), elderly patients frequently display an atypical "apathetic" phenotype. This apathetic presentation lacks dramatic hypermetabolic features but carries a high risk of covert, life-threatening cardiac complications. From a diagnostic standpoint, the Japan Thyroid Association (JTA) guidelines mandate objective biochemical confirmation using a combinatory algorithm, whereas the Burch-Wartofsky Point Scale (BWPS) relies on a cumulative, symptom-weighted score. Emergency management requires a strict, multi-targeted pharmacological regimen: beta-blockers (propranolol or esmolol) for hyperadrenergic cardiotoxicity, thionamides to halt hormone synthesis, timed inorganic iodine to block hormone release, and glucocorticoids to counter relative adrenal insufficiency. Refractory circulatory collapse requires advanced extracorporeal rescue systems, including therapeutic plasma exchange (TPE) and Extracorporeal Membrane Oxygenation (ECMO). Conclusion: Combating the high mortality of a thyroid storm depends on a seamless, interprofessional continuum of care. Primary care physicians form the first line of defense through outpatient risk mitigation and medication optimization. When a crisis occurs, emergency clinicians must prioritize clinical acumen over rigid scoring algorithms, especially in apathetic presentations, to immediately initiate aggressive stabilization and secure prompt intensive care unit (ICU) containment.

12 October 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ABAgnieszka Benecka
Agnieszka Benecka
KKKrystian Kaczmarek
Krystian Kaczmarek
WZWiktoria Zawada
Wiktoria Zawada
ZLZofia Jadwiga Leszczyńska
Zofia Jadwiga Leszczyńska
VRVladyslav Romaniuk
Vladyslav Romaniuk
MKMarcin Kutkowski
Marcin Kutkowski
Caffeine is one of the most widely consumed psychoactive substances and a well-established ergogenic aid in both athletic and cognitive performance contexts. The aim of this review was to evaluate the effects of caffeine supplementation on physical performance and cognitive function, with particular emphasis on dosage strategies, timing of ingestion, and individual variability in response. A narrative review of recent literature published between 2020 and 2025 was conducted using major scientific databases. The analysis included randomized controlled trials, systematic reviews, and meta-analyses investigating the impact of caffeine on exercise capacity, neuromuscular performance, and cognitive outcomes. The findings indicate that caffeine supplementation in doses ranging from 3 to 6 mg/kg body mass significantly enhances strength, power, and endurance performance. In addition, caffeine improves cognitive functions such as attention, reaction time, and alertness, particularly under conditions of fatigue. The ergogenic effects are primarily attributed to the antagonism of adenosine receptors and increased central nervous system stimulation. However, the response to caffeine varies considerably among individuals due to genetic factors, habitual intake, and sensitivity to stimulants. Excessive consumption may lead to adverse effects, including sleep disturbances, anxiety, and cardiovascular responses. In conclusion, caffeine represents an effective and accessible strategy for improving both physical and cognitive performance. Nevertheless, its optimal application requires individualized dosing, appropriate timing, and careful monitoring to maximize benefits while minimizing potential risks.

20 May 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
WZWiktoria Zawada
Wiktoria Zawada
ITIga Tartas
Iga Tartas
KKKrystian Kaczmarek
Krystian Kaczmarek
ZLZofia Jadwiga Leszczyńska
Zofia Jadwiga Leszczyńska
VRVladyslav Romaniuk
Vladyslav Romaniuk
NPNatalia Prankiewicz
Natalia Prankiewicz
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive joint inflammation and multifactoral pathogenesis. Growing evidence indicates that the intestinal microbiota plays significant role in disease development and progression. Gut microbiota contributes to immune homeostasis, while dysbiosis-defined as altered microbial composition is associated with reduced diversity,expansion of pro-inflammatory taxa such as Prevotella copri and depletion of beneficial commensals. This review summarizes key mechanisms linking gut microbiota with RA, including increased intestinal permeability, immune dysregulation with Th17/Treg imbalance, molecular mimicry and altered production of microbial metabolites, particularly short-chain fatty acids. These processes are integrated within the concept of the gut-joint axis, explaining how intestinal disturbances may contribute to systemic and synovial inflammation. The potential of microbiota-derived biomarkers for diagnosis, prognosis and treatment response is also discussed. Additionally, emerging therapeutic strategies targeting gut microbiota, such as dietary interventions, probiotics and fecal microbiota transplantation are reviewed. Although promising, these approaches require further validation before clinical application.

22 June 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
USUrszula Szuleta
Urszula Szuleta
WZWiktoria Zawada
Wiktoria Zawada
KKKrystian Kaczmarek
Krystian Kaczmarek
ZLZofia Jadwiga Leszczyńska
Zofia Jadwiga Leszczyńska
VRVladyslav Romaniuk
Vladyslav Romaniuk
NPNatalia Prankiewicz
Natalia Prankiewicz
Introduction and purpose. Major depressive disorder is a serious clinical problem. Current treatments are often unsuccessful, and many patients do not achieve full remission. In a reanalysis of the STAR*D study, the cumulative remission rate after up to four treatment steps was about 41%, which highlights the limitations of currently available antidepressant strategies[1]. In recent years, growing attention has been paid to novel agents with potential rapid antidepressant effects. Among them, ketamine and its derivatives have become the subject of numerous studies evaluating their role in depressive disorders, particularly in treatment-resistant depression [2]. The aim of this review is to summarize current evidence regarding the efficacy, safety, and clinical use of ketamine and its derivatives in depression, with particular emphasis on treatment-resistant depression. A brief description of the state of knowledge. This review presents current evidence on novel therapeutic agents that may be useful in the treatment of severe depression. It discusses the concept of severe depression and its broader clinical and social consequences. Particular attention is given to the mechanisms of action of ketamine and its derivatives, the available evidence on their efficacy, their adverse effects, and their potential impact on suicidal ideation. The review also emphasises the limitations of existing data and the need for further research. Summary (conclusions). Current data indicate that ketamine is a promising option for the treatment of drug-resistant and severe depression because of its rapid onset of action. Some evidence suggests that it may reduce suicidal ideation in high-risk patients, however further large-scale, long-term studies are needed to clarify the durability of benefit and long-term safety. [2,3,4].

7 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JPJakub Pietrończyk
Jakub Pietrończyk
KKKrystian Kaczmarek
Krystian Kaczmarek
ZWZuzanna Wieczorek
Zuzanna Wieczorek
WZWiktoria Zawada
Wiktoria Zawada
ITIga Tartas
Iga Tartas
ZLZofia Jadwiga Leszczyńska
Zofia Jadwiga Leszczyńska
Background. Cardiovascular disease is one of the leading causes of morbidity and mortality worldwide. Physical inactivity and sedentary behavior are important modifiable risk factors. Cardiorespiratory fitness (CRF), often expressed as VO2max, VO2peak, metabolic equivalents (METs), exercise capacity, or estimated CRF, has gained attention as a predictor of cardiovascular and overall health. Aim. This review evaluated the prognostic significance of CRF in relation to cardiovascular risk, cardiovascular outcomes, cardiovascular mortality, all-cause mortality, and premature mortality in adults. Materials and methods. This narrative review was based on English-language publications identified in PubMed and Google Scholar. Meta-analyses, systematic reviews, observational cohort studies, clinical reviews, expert statements, and interventional studies relevant to cardiorespiratory fitness, exercise capacity, cardiovascular prevention, mortality, and cardiac rehabilitation were included in the synthesis. Results. The reviewed evidence consistently indicates that higher CRF is associated with a lower risk of all-cause mortality, cardiovascular mortality, and cardiovascular events. This relationship has been observed using various assessment methods, including directly measured VO2max or VO2peak, treadmill-derived peak METs, exercise capacity, and estimated CRF. CRF also appears to have prognostic value in populations with obesity, diabetes, hypertension, coronary artery disease, and heart failure. Changes in CRF over time may be associated with changes in mortality risk. These findings support the interpretation of CRF as a modifiable prognostic marker. Conclusions. CRF should be regarded as a measure of physical performance as well as an indicator of cardiovascular, respiratory, metabolic, and functional health. Its assessment may support cardiovascular risk stratification, prevention, and rehabilitation strategies in adult populations.